SA
LH icon

Seneschal Advisors’s Labcorp LH Stock Holding History

Seneschal Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$560 Hold
2
– – ﹤0.01% 375
2026
Q1 		$534 Hold
2
– – ﹤0.01% 353
2025
Q4 		$502 Hold
2
– – ﹤0.01% 360
2025
Q3 		$575 Buy
+2
New +$536 ﹤0.01% 328

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Seneschal Advisors's LH Position: Q2 2026 in Review

Seneschal Advisors held its Labcorp (LH) position steady in Q2 2026 at 2 shares worth $560. The position accounts for ﹤0.01% of the portfolio, ranked #375.

Seneschal Advisors first reported a position in LH in Q3 2025 and has held it in 4 quarters since. The position peaked at $575 in Q3 2025. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Seneschal Advisors held 2 shares of Labcorp worth $560 as of Q2 2026.
  • Seneschal Advisors left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #375 holding.
  • Seneschal Advisors first reported a position in Labcorp in Q3 2025 and has held it in 4 quarters since.
  • Seneschal Advisors's Labcorp position peaked at $575 in Q3 2025.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.